- Home
- ATKR vs IRON Comparison
ATKR vs IRON Comparison
Compare ATKR & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATKR
- IRON
- Stock Information
- Founded
- ATKR 1959
- IRON 2017
- Country
- ATKR United States
- IRON United States
- Employees
- ATKR N/A
- IRON N/A
- Industry
- ATKR Industrial Machinery/Components
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- ATKR Miscellaneous
- IRON Health Care
- Exchange
- ATKR Nasdaq
- IRON Nasdaq
- Market Cap
- ATKR 2.2B
- IRON 2.1B
- IPO Year
- ATKR 2016
- IRON N/A
- Fundamental
- Price
- ATKR $66.12
- IRON $76.98
- Analyst Decision
- ATKR Hold
- IRON Strong Buy
- Analyst Count
- ATKR 6
- IRON 10
- Target Price
- ATKR $81.00
- IRON $97.80
- AVG Volume (30 Days)
- ATKR 617.6K
- IRON 392.9K
- Earning Date
- ATKR 11-20-2025
- IRON 11-11-2025
- Dividend Yield
- ATKR 2.05%
- IRON N/A
- EPS Growth
- ATKR N/A
- IRON N/A
- EPS
- ATKR 3.22
- IRON N/A
- Revenue
- ATKR $2,886,664,000.00
- IRON N/A
- Revenue This Year
- ATKR N/A
- IRON N/A
- Revenue Next Year
- ATKR N/A
- IRON N/A
- P/E Ratio
- ATKR $20.52
- IRON N/A
- Revenue Growth
- ATKR N/A
- IRON N/A
- 52 Week Low
- ATKR $49.92
- IRON $30.82
- 52 Week High
- ATKR $105.28
- IRON $78.17
- Technical
- Relative Strength Index (RSI)
- ATKR 63.19
- IRON 80.26
- Support Level
- ATKR $61.83
- IRON $68.82
- Resistance Level
- ATKR $64.77
- IRON $72.68
- Average True Range (ATR)
- ATKR 2.08
- IRON 2.86
- MACD
- ATKR 0.29
- IRON 0.83
- Stochastic Oscillator
- ATKR 94.25
- IRON 94.26
About ATKR Atkore Inc.
Atkore Inc is a diversified industrials company and a manufacturer of electrical, mechanical, and safety infrastructure solutions. Atkore has two business segments; Electrical and Safety and Infrastructure. Net sales are highest in the electrical business line. The key product categories in the electrical segment are PVC conduit, steel conduit, and PVC-coated conduit, which are staples for electrical distributors. The key product categories in the safety and infrastructure segment include in-line galvanized mechanical tubes, metal framing and related fittings, and security bollards. Also, the company provides ancillary services to customers in the form of slitting and cutting structural steel sheets. Geographically, the company derives its key revenue from the United States.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.